Top Markets
#1 Black Phoenix Black Phoenix +367.29%
#2 Islamic Coin Islamic Coin +158.24%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.02%
#5 Akedo Akedo +52.28%
#6 Acurast Acurast +37.40%
#7 BasedHype BasedHype +30.34%
#8 Cryptopia Cryptopia +22.42%
#9 Avantis Avantis +21.94%
#10 Playnance Playnance +18.37%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Sangui Biotech International, Inc. Sangui Biotech International, Inc.

Sangui Biotech International, Inc.

SGBI
Classement en actions #41118
Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH,... Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH, specializes in creating artificial oxygen carriers derived from hemoglobin. These innovative products are utilized as blood supplements, blood volume replacements, and various related formulations. The company's oxygen carriers are vital for delivering oxygen to humans experiencing acute or chronic oxygen deprivation due to conditions like blocked arteries, anemia, or blood loss, as well as for managing chronic wounds. Their product line also includes nano-formulations designed for skin regeneration, enhancing moisture and elasticity. Furthermore, they provide Chitoskin wound pads to aid in healing and Hemospray, a medical-grade spray specifically formulated for treating persistent wounds. The wound spray products, marketed under the Granulox brand, are primarily distributed in Europe and Mexico, while their cosmetic items are available through an online store. Established in 1995, Sangui Biotech International, Inc. is based in Hamburg, Germany.
Prix de l'action
$0.0002
Dernière synchronisation: 2025-07-02
Capitalisation boursière
$41.98K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
DE
Échange Sangui Biotech International, Inc. (SGBI)

Catégorie

Healthcare
Revenus pour Sangui Biotech International, Inc. (SGBI)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de Sangui Biotech International, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Sangui Biotech International, Inc. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN